Replies to post #6319 on Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[ericteg]

Just to elaborate on an earlier comments regarding the conference call, someone on the Yahoo board said that the other 2 investment companies that asked questions were Stanford Capital and Punch & Associates.

This person also felt that the presence of the analysts meant that the uplisting was imminent and that the recent change in the handling of the debentures in terms of the income statement and balance sheet may have been mandated by NASDAQ as part of their "comments" and that hopefully, JGBO's change in their 10Q reporting will be the key to trigger the approval for the uplist in the near future.